Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily E Morin

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Frontiers in Endocrinology|December 18, 2018
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential TherapeuticEmily E Morin, Xiang-An Li, Anna Schwendeman
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
ReplyMinzhi Yu, Sang Y Kim, Emily E Morin, et al.
Frontiers in Pharmacology|November 12, 2015
HDL in sepsis - risk factor and therapeutic approachEmily E Morin, Ling Guo, Anna Schwendeman, et al.
Accounts of Chemical Research|August 20, 2019
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and FailuresHongliang He, Lisha Liu, Emily E Morin, et al.
Microcirculation (New York, N.Y. : 1994)|June 11, 2022
Endothelial cell membrane cholesterol content regulates the contribution of TRPV4 channels in ACh-induced vasodilation in rat gracilis arteriesEmily E Morin, Sophia Salbato, Benjimen R Walker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2019
High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic StrategySang Yeop Kim, Minzhi Yu, Emily E Morin, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Role of Cholesterol in the Regulation of Hydrogen Sulfide Signaling within the Vascular EndotheliumPerenkita J Mendiola, Emily E Morin, Laura V Gonzalez Bosc, et al.
Advanced Drug Delivery Reviews|July 17, 2018
Battle of GLP-1 delivery technologiesMinzhi Yu, Mason M Benjamin, Santhanakrishnan Srinivasan, et al.
Endocrinology|June 3, 2016
Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal CellsMatthew J Taylor, Aalok R Sanjanwala, Emily E Morin, et al.
Frontiers in Pharmacology|January 4, 2021
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in MiceEmily E Morin, Yanhong Guo, Hongliang He, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|December 18, 2018
HDL in Endocrine Carcinomas: Biomarker, Drug Carrier, and Potential TherapeuticEmily E Morin, Xiang-An Li, Anna Schwendeman
Arthritis & Rheumatology (Hoboken, N.J.)|February 28, 2020
ReplyMinzhi Yu, Sang Y Kim, Emily E Morin, et al.
Frontiers in Pharmacology|November 12, 2015
HDL in sepsis - risk factor and therapeutic approachEmily E Morin, Ling Guo, Anna Schwendeman, et al.
Accounts of Chemical Research|August 20, 2019
Survey of Clinical Translation of Cancer Nanomedicines-Lessons Learned from Successes and FailuresHongliang He, Lisha Liu, Emily E Morin, et al.
Microcirculation (New York, N.Y. : 1994)|June 11, 2022
Endothelial cell membrane cholesterol content regulates the contribution of TRPV4 channels in ACh-induced vasodilation in rat gracilis arteriesEmily E Morin, Sophia Salbato, Benjimen R Walker, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 28, 2019
High-Density Lipoprotein in Lupus: Disease Biomarkers and Potential Therapeutic StrategySang Yeop Kim, Minzhi Yu, Emily E Morin, et al.
Antioxidants (Basel, Switzerland)|September 23, 2022
Role of Cholesterol in the Regulation of Hydrogen Sulfide Signaling within the Vascular EndotheliumPerenkita J Mendiola, Emily E Morin, Laura V Gonzalez Bosc, et al.
Advanced Drug Delivery Reviews|July 17, 2018
Battle of GLP-1 delivery technologiesMinzhi Yu, Mason M Benjamin, Santhanakrishnan Srinivasan, et al.
Endocrinology|June 3, 2016
Synthetic High-Density Lipoprotein (sHDL) Inhibits Steroid Production in HAC15 Adrenal CellsMatthew J Taylor, Aalok R Sanjanwala, Emily E Morin, et al.
Frontiers in Pharmacology|January 4, 2021
Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in MiceEmily E Morin, Yanhong Guo, Hongliang He, et al.
Pageof 2